Sigrid Therapeutics
  • Sigrid Therapeutics
  • Quotes
  • Share:
  • Subscribe:
  • news.cision.com/
  • Sigrid Therapeutics/
  • Sigrid Therapeutics to Present SHINE Trial Results at EASD 2025 Annual Meeting/
  • Tore Bengtsson founder headshot

Tore Bengtsson founder headshot

Tue, Jun 03, 2025 08:00 CET

Low resolution

Medium resolution

Original resolution

Subscribe

Related Releases

Sigrid’s CarbFence™ Delivers Appetite Control, Muscle-Preserving Weight Loss, and Exceptional Safety - Positioned for Global Roll-Out Mon, Aug 18, 2025 08:00 CET
Sigrid Therapeutics Completes Enrollment in SHINE to Evaluate SiPore21® Gel for Sustained Blood Sugar and Weight Management Tue, Jul 30, 2024 08:30 CET
Sigrid Therapeutics Surpasses the 50% Enrollment Milestone in its Clinical Trial, SHINE, to Evaluate the SiPore21® Gel for Sustained Diabetes and Obesity Control Tue, Apr 30, 2024 08:30 CET
©Cision
Privacy statement | Cookies | About | Content Policy | Contact    Cision
©Cision Privacy statement Cookies About Content Policy Contact

   Cision